Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
no credit check payday loan
Popular Articles
Stretch Mark

Researchers Pinpoint A New Enemy For Tumor Suppressor P53
Researchers at The University of Texas M. D. Anderson Cancer Center have identified a protein that marks the tumor suppressor p53 for destruction, providing a potential new avenue for restoring p53 in cancer cells.
generic viagra online
Researchers At The University Of Tennessee Health Science Center Begin New Study On Parkinson's Disease
Researchers at the University of Tennessee Health Science Center (UTHSC) are recruiting participants for a national clinical study of medication that could slow the progression of Parkinson"s disease. The study, referred to as "QE3," will examine the effectiveness of the research medication Coenzyme Q10 (CoQ). During the study, investigators will administer high doses of CoQ to participants 30 years of age or older with early stage Parkinson"s disease to reduce the speed of their physical decline. The research is sponsored by the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health (NIH), and will be conducted by the Parkinson Study Group, an international council of physicians and researchers experienced in caring for Parkinson"s patients and studying the disease.
News of the day
USC Researchers Uncover Mechanism That Allows Influenza Virus To Evade The BodyÂðs Immune Response
California (USC) have identified a
Cardiovascular

Oxoid Provides Free Infection Control Seminar In The UK

Oxoid, a world leading microbiology brand, is pleased to announce that the next Oxoid Infection Control Seminar will take place on 02 June 2009 at The Belfry, West Midlands, UK. This all-day event is completely free of charge and is provided as an educational service to consultant microbiologists, laboratory managers/personnel and infection control professionals. This year"s topics and speakers include: - An outbreak of the new superbug - MSSA (Dr Tim Boswell Nottingham University Hospital NHS Trust) - The implications of PVL for infection control (Angela Kearns, Health Protection Agency) - Implications and benefits of implementation of MRSA screening policy (Steve Farley and Yashpal Delele, Dudley Group of Hospitals NHS Trust) - European Committee on Antimicrobial Susceptibility Testing (EUCAST) Update, (Gunnar Kahlmeter, Vç¤xjç¶ Hospital, Sweden) - New technology, friend or foe - how infection control needs are impacting hospital design (Martin Kiernan, President of the Infection Prevention Society) - Standards and Performance Indicators for Healthcare Associate Infections and Antimicrobial Resistance in Europe (Professor Barry Cookson, Health Protection Agency). This study day is accredited by the Institute of Biomedical Scientists (7 credits) and the Royal College of Pathologists (5 credits) and accreditation from the Royal College of Nursing has been sought. The seminar is also a great opportunity to mix with colleagues and share current thinking on healthcare associated infection and infection control matters during the coffee and lunch breaks. So make sure you reserve the date and your FREE place by contacting Fiona Macrae, seminar manager, email: oxoid.awards@thermofisher.com tel: 01256 841144. Places are limited and are allocated on a first come, first served basis. Lunch is provided, but travel and accommodation are not included in this offer. Oxoid is part of Thermo Fisher Scientific Inc., the world leader in serving science. Thermo Fisher Scientific


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009